EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis

Anton Öberg Sysojev iD, Bénédicte Delcoigne, Thomas Frisell, Lars Alfredsson, Lars Klareskog iD, SRQ biobank group, Saedis Saevarsdottir, Magnus Boman, Leonid Padyukov, Johan Askling, Helga Westerlind iD

Journal of Internal Medicine · 2025

DOI: 10.1111/joim.20087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Anton Öberg Sysojev und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Antirheumatic Agents, Genetic Variation. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Hjärt-Lungfonden, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methotrexate (MTX) is the mainstay initial treatment of rheumatoid arthritis (RA), but individual response varies and remains difficult to predict. The role of genetics remains unclear, but studies suggest its importance.

Methods

Incident RA patients starting MTX‐monotherapy were identified through a large‐scale Swedish register linkage. Demographic, clinical, medical, and drug history features were combined with fully imputed genotype data and used to train and evaluate multiple learning models to predict key MTX treatment outcomes.

Results

Among 2432 patients, we consistently observed an estimated area under the curve (AUC) of ∼0.62, outperforming models trained on sex and age. The best performance was observed for EULAR primary response (AUC = 0.67), whereas models struggled the most with predicting discontinuation. Genetics provided negligible improvements to prediction quality.

Conclusions

Despite an extensive study population with broad multi‐modal data, predicting MTX treatment outcomes remains a challenge. Common genetic variants added minimal predictive power over clinical features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidAntirheumatic AgentsGenetic VariationHumansMaleFemaleMiddle AgedTreatment OutcomeAgedSwedenAdultRegistriesGenotype

Stichwörter der Autor:innen

machine learningmethotrexatepharmacogeneticspolymorphismrheumatoid arthritissingle nucleotide

Substanzen

MethotrexateAntirheumatic Agents

Autor:innen und Institutionen

  • Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden.
  • Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Center for Molecular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • MedTechLabs, BioClinicum, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Anton Öberg Sysojev, Lars Klareskog, Helga Westerlind

Förderung

  • Cancerfonden
  • Hjärt-Lungfonden
  • Karolinska Institutet
  • Nordforsk
  • Reumatikerförbundet
  • Stiftelsen Konung Gustaf V:s 80-årsfond
  • Stiftelsen Professor Nanna Svartz Fond
  • Vinnova

Zitieren

APA

Sysojev, A. Ö., Delcoigne, B., Frisell, T., Alfredsson, L., Klareskog, L., SRQ biobank group, Saevarsdottir, S., Boman, M., Padyukov, L., Askling, J., & Westerlind, H. (2025). Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis. Journal of Internal Medicine. https://doi.org/10.1111/joim.20087

Vancouver

Sysojev AÖ, Delcoigne B, Frisell T, Alfredsson L, Klareskog L, SRQ biobank group, et al. Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis. Journal of Internal Medicine. 2025. doi:10.1111/joim.20087

BibTeX
@article{Sysojev2025,
  author = {Sysojev, Anton Öberg and Delcoigne, Bénédicte and Frisell, Thomas and Alfredsson, Lars and Klareskog, Lars and SRQ biobank group, SRQ biobank group and Saevarsdottir, Saedis and Boman, Magnus and Padyukov, Leonid and Askling, Johan and Westerlind, Helga},
  title = {Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis},
  journal = {Journal of Internal Medicine},
  year = {2025},
  doi = {10.1111/joim.20087}
}
Kostenlos starten →